Association of C677T gene polymorphism of methylenetetrahydrofolate reductase with insulin resistance among Kirghizes

Kardiologiya

Volumn 51, Issue 3, 2011, Pages 58-62

  Lunegova, O S ^a   Kerimkulova, A S ^a   Turdakmatov, N B ^a   Sovhosova, N A ^a   Nabiev, M P ^a   Isakova, Z T ^a   Yusupova, E U ^a   Moldokeeva, Ch B ^a   Gotfrid , I Y ^a   Mirrakhimov, A E ^a   Aldasheva, N M ^a   Heyer, E ^a   Aldashev, A A ^a   Mirrakhimov, E M ^a  

^a NONE

Author keywords

C677T polymorphism of MTHFR gene; Diabetes mellitus; Insulin resistance

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ABDOMINAL OBESITY; ADULT; AGED; ALLELE; ARTICLE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; KYRGYZSTAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; ALLELES; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; KYRGYZSTAN; MALE; METABOLIC SYNDROME X; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OBESITY, ABDOMINAL; POLYMORPHISM, GENETIC;

EID: 79960956935     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ueland P. M., Refsum H., Brattstrom L. Plasma homocysteine and cardiovascular disease. In Francis R. B. Jr, ed. Atherosclerotic cardiovascular disease, hemostasis and endothelial function. New York Marcel Dekker Inc 1992:183-236.
2. Trabetti E. Homocysteine, MTHFR gene polymorphisms and cardiovascular risk. J Appl Genet 49:267-282.
3. Hoogeven E. K., Kostense P. J., Beks P. J. et al. Hyperhomocysteinemia is associated with increased risk of cardiovascular disease, especially in noninsulin-dependent diabetes mellitus: a population-based study. Atheroscler Thromb Vasc Biol 1998;18:133-138.
4. Becker A., Kostense P. J., Bos G. et al. Hyperhomocysteinemia is associated with coronary events in type 2 diabetes. J Intern Med 2003;253:293-300.
5. Bailey L. B., Gregory J. F. Polymorphisms of methylenetetrahydrofotate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 1999;129:148-160.
6. Blom H. J., Verhoef P. Hyperhomocysteinemia, MTHFR and risk of vascular disease. Circulation 2000;101:E171.
7. Fridewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
8. Grundy S. M., Cleeman J. I., Daniels S. R. et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Curr Opin Cardiol 2006;21:1-6.
9. Rutherford J. D., Braunwald E. Chronic ischemic heart disease. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicines. 4th ed. Philadelphia: WB Saunders 1992:1293-1295.
10. Schneider J. A., Rees D. C., Liu Y. T. et al. Worldwide distribution of common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998;62:1258-1260.
11. Giltay E. J., Hoogeveen E. K., Elbers J. M. H. et al. Insulin resistance is associated with elevated plasma homocysteine levels in healthy, non-obese subjects. Atherosclerosis 1998;139:197-198.
12. Meigs J. B., Jacques P. F., Selhub J. et al. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care 2001;24:1403-1410.
13. Fonseca V., Dicker-Brown A., Ranganalhan S. et al. Effects of a high-fatsucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 2000;49:736-741.
14. Ratnam S., Maclean K. N., Jacobs R. L. et al. Hormonal regulation of cystathionine-beta-synthase expression in liver. J Biol Chem 2002;277:42912-42918.
15. Fonesca V. A., Mudaliar S., Schmidt B. et al. Plasma homocysteine concentration are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetes subjects. Metabolism 1998;47:686-689.
16. Sanchez-Margalet V., Valle M., Ruz F. J. et al. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 2002;13:75-79.
17. Fonesca V. A., Keebler M., Dicker-Brown A. et al. The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine and S-adenosyl homocysteine and enzymes in homocystein metabolism in Zucker rats. Metabolism 2002;51:783-786.
18. Terruzzi I., Senesi P., Fermo I. et al. Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity. J Endocrinol Invest 2007;30:747-753.
19. Thawnashom K., Tungtrongchitr R., Petmitr S. et al. Methylene- tetrahydrofolate reductase (MTHFR) polymorphism (C677T) in relation to homocysteine concentration in overweight and obese Thais. Southeast Asian J Trop Med Public Health 2005;36:459-466.